United Kingdom Biotechnology & Medical Research

Amarin Corporation PLC (AMRN)

Track

Amarin Corporation PLC has seen no insider trading activity within the last 90 days. The most recent transaction occurred on August 2, 2024, when President and CEO Aaron Berg purchased 160,000 shares. Prior to this, historical activity included various buy transactions and planned sales by company executives.
Ticker: AMRN Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Amarin Corporation PLC. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 2 Aug 2024
Value US$2,872,748.44 | Price 346.64 | Shares 58,973 (-29.4%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-08-05 2024-08-02 B Purchase
0.9
Berg Aaron

President and CEO

Officer
58,973 -29.4%
346.64
US$2,872,748 		58,973 -29.4% 346.64 US$2,872,748
2024-01-24 2024-01-22 B Purchase
1.3
Holt Patrick

President and CEO

Executive Director
73,694 -2.9%
328.92
US$4,636,407 		73,694 -2.9% 328.92 US$4,636,407
2023-12-14 2023-12-12 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
24,287 -35.0%
90.24
US$3,867,757 		24,287 -35.0% 90.24 US$3,867,757
2023-12-12 2023-12-12 PrS Proposed sale
STEVEN B. KETCHUM

Officer

Officer
34,131
0.84
US$28,564 		34,131 0.84 US$28,564
2023-08-16 2023-08-16 B Purchase
1.3
Holt Patrick

President and CEO

Executive Director
67,222 +28.9%
1.06
US$71,255 		67,222 +28.9% 1.06 US$71,255
2023-08-16 2023-08-16 B Purchase
1.3
Holt Patrick

President and CEO

Executive Director
25,845 +12.4%
1.06
US$27,266 		25,845 +12.4% 1.06 US$27,266
2023-08-16 2023-08-16 B Purchase
1.3
Holt Patrick

President and CEO

Executive Director
12,700 +6.5%
1.05
US$13,335 		12,700 +6.5% 1.05 US$13,335
2023-08-16 2023-08-16 B Purchase
1.3
Holt Patrick

President and CEO

Executive Director
30,642 +18.7%
1.04
US$31,868 		30,642 +18.7% 1.04 US$31,868
2023-08-16 2023-08-16 B Purchase
1.3
Holt Patrick

President and CEO

Executive Director
19,358 +13.4%
1.04
US$20,036 		19,358 +13.4% 1.04 US$20,036
2023-08-16 2023-08-16 B Purchase
1.3
Holt Patrick

President and CEO

Executive Director
143,275 +14955.6%
1.03
US$147,573 		143,275 +14955.6% 1.03 US$147,573
2023-08-16 2023-08-16 B Purchase
1.3
Holt Patrick

President and CEO

Executive Director
958 +inf%
1.03
US$982 		958 +inf% 1.03 US$982
2022-06-15 2022-06-13 B Purchase
1.4
WOLD OLSEN PER
Non-Executive Director
55,000 +58.5%
1.69
US$92,730 		55,000 +58.5% 1.69 US$92,730
2021-12-16 2021-12-15 B Purchase
4.3
Zakrzewski Joseph S
Non-Executive Director
2,000 +1.0%
3.16
US$6,310 		2,000 +1.0% 3.16 US$6,310
2021-12-16 2021-12-14 B Purchase
4.3
Zakrzewski Joseph S
Non-Executive Director
10,000 +5.4%
3.27
US$32,689 		10,000 +5.4% 3.27 US$32,689
2021-06-07 2021-06-04 B Purchase
2.8
STACK DAVID M
Non-Executive Director
10,000 +33.3%
4.54
US$45,350 		10,000 +33.3% 4.54 US$45,350
2021-06-07 2021-06-03 B Purchase
2.8
STACK DAVID M
Non-Executive Director
5,000 +20.0%
4.62
US$23,115 		5,000 +20.0% 4.62 US$23,115
2021-02-03 2021-02-01 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
25,370 -6.2%
8.03
US$203,670 		25,370 -6.2% 8.03 US$203,670
2021-02-03 2021-02-01 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
192,358 -32.0%
8.06
US$1,550,463 		192,358 -32.0% 8.06 US$1,550,463
2021-01-29 2021-01-27 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
143,392 -27.0%
8.01
US$1,149,258 		143,392 -27.0% 8.01 US$1,149,258
2021-01-29 2021-01-27 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
278,237 -34.4%
8.01
US$2,228,873 		278,237 -34.4% 8.01 US$2,228,873
2020-12-02 2020-11-30 B Purchase
2.8
STACK DAVID M
Non-Executive Director
25,000 +inf%
4.86
US$121,518 		25,000 +inf% 4.86 US$121,518
2020-11-12 2020-11-11 S Sale
1.3
THERO JOHN F

President and CEO

Executive Director
413,565 -13.1%
4.07
US$1,681,183 		413,565 -13.1% 4.07 US$1,681,183
2020-11-12 2020-11-10 S Sale
1.3
THERO JOHN F

President and CEO

Executive Director
153,840 -4.7%
4.13
US$635,975 		153,840 -4.7% 4.13 US$635,975
2020-03-06 2020-03-04 PlS Planned sale
1.3
THERO JOHN F

President and CEO
200,000 -7.5%
15.99
US$3,198,700 		200,000 -7.5% 15.99 US$3,198,700
2020-01-03 2020-01-03 PlS Planned sale
4.3
Zakrzewski Joseph S
300,000 -78.0%
20.94
US$6,282,870 		300,000 -78.0% 20.94 US$6,282,870
2019-12-18 2019-12-16 PlS Planned sale Zakrzewski Joseph S Non-Executive Director
100,000 -54.2%
25.83
US$2,583,380 		100,000 -54.2% 25.83 US$2,583,380
2019-12-18 2019-12-16 PlS Planned sale Berg Aaron

CHIEF COMMERCIAL OFFICER

Officer
43,253 -24.4%
25.46
US$1,101,364 		43,253 -24.4% 25.46 US$1,101,364
2019-12-18 2019-12-16 PlS Planned sale Kalb Michael Wayne

SVP and CFO

Officer
100 -0.5%
25.66
US$2,566 		100 -0.5% 25.66 US$2,566
2019-12-18 2019-12-16 PlS Planned sale Kalb Michael Wayne

SVP and CFO

Officer
1,000 -4.4%
24.84
US$24,836 		1,000 -4.4% 24.84 US$24,836
2019-12-18 2019-12-16 PlS Planned sale Kalb Michael Wayne

SVP and CFO

Officer
7,500 -24.9%
23.81
US$178,586 		7,500 -24.9% 23.81 US$178,586
2019-12-18 2019-12-16 PlS Planned sale Kalb Michael Wayne

SVP and CFO

Officer
16,400 -35.2%
23.05
US$378,023 		16,400 -35.2% 23.05 US$378,023
2019-11-21 2019-11-19 PlS Planned sale THERO JOHN F

President and CEO

Executive Director
274,454 -10.5%
22.65
US$6,217,371 		274,454 -10.5% 22.65 US$6,217,371
2019-11-13 2019-11-12 PlS Planned sale Ekman Lars Non-Executive Director
38,600 -100.0%
19.35
US$746,759 		38,600 -100.0% 19.35 US$746,759
2019-11-13 2019-11-11 PlS Planned sale THERO JOHN F

President and CEO

Executive Director
41,741 -1.6%
17.88
US$746,296 		41,741 -1.6% 17.88 US$746,296
2019-11-13 2019-11-11 PlS Planned sale THERO JOHN F

President and CEO

Executive Director
433,805 -14.0%
17.05
US$7,397,156 		433,805 -14.0% 17.05 US$7,397,156
2019-11-07 2019-11-05 PlS Planned sale
Ekman Lars
6,400 -100.0%
18.00
US$115,230 		6,400 -100.0% 18.00 US$115,230
2019-09-05 2019-09-03 PlS Planned sale
Ekman Lars
91,016 -100.0%
15.01
US$1,365,722 		91,016 -100.0% 15.01 US$1,365,722
2019-07-12 2019-07-11 PlS Planned sale
2.8
STACK DAVID M
51,991 -100.0%
22.28
US$1,158,354 		51,991 -100.0% 22.28 US$1,158,354
2019-07-05 2019-07-05 PlS Planned sale
4.3
Zakrzewski Joseph S
100,000 -54.2%
23.82
US$2,381,580 		100,000 -54.2% 23.82 US$2,381,580
2019-07-03 2019-07-03 PlS Planned sale
0.9
Berg Aaron

CHIEF COMMERCIAL OFFICER
29,250 -44.6%
22.64
US$662,238 		29,250 -44.6% 22.64 US$662,238
2019-07-03 2019-07-02 PlS Planned sale
0.9
Berg Aaron

CHIEF COMMERCIAL OFFICER
19,564 -35.0%
21.42
US$419,061 		19,564 -35.0% 21.42 US$419,061
2019-07-03 2019-07-02 PlS Planned sale
0.9
Berg Aaron

CHIEF COMMERCIAL OFFICER
50,000 -47.2%
20.46
US$1,023,080 		50,000 -47.2% 20.46 US$1,023,080
2019-07-03 2019-07-01 PlS Planned sale
Kennedy Joseph T

General Counsel
54,186 -63.4%
19.52
US$1,057,906 		54,186 -63.4% 19.52 US$1,057,906
2019-07-03 2019-07-01 PlS Planned sale
Kalb Michael Wayne

SVP and CFO
50,000 -70.6%
19.67
US$983,270 		50,000 -70.6% 19.67 US$983,270
2019-06-26 2019-06-24 PlS Planned sale
0.9
Berg Aaron

CHIEF COMMERCIAL OFFICER
113,195 -75.7%
18.59
US$2,104,521 		113,195 -75.7% 18.59 US$2,104,521
2019-06-20 2019-06-18 PlS Planned sale
4.3
Zakrzewski Joseph S
100,000 -54.2%
19.02
US$1,902,090 		100,000 -54.2% 19.02 US$1,902,090
2019-05-31 2019-05-31 PlS Planned sale
Kennedy Joseph T

General Counsel
27,229 -46.6%
17.92
US$488,058 		27,229 -46.6% 17.92 US$488,058
2019-05-31 2019-05-29 PlS Planned sale
2.8
STACK DAVID M
Non-Executive Director
33,799 -100.0%
18.45
US$623,534 		33,799 -100.0% 18.45 US$623,534
2019-05-21 2019-05-17 PlS Planned sale
2.8
STACK DAVID M
Non-Executive Director
13,174 -100.0%
18.00
US$237,139 		13,174 -100.0% 18.00 US$237,139
2019-05-02 2019-04-30 PlS Planned sale
Kennedy Joseph T

General Counsel
27,230 -46.6%
18.69
US$508,839 		27,230 -46.6% 18.69 US$508,839
2019-05-02 2019-04-30 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
9,541 -2.6%
18.67
US$178,107 		9,541 -2.6% 18.67 US$178,107
2019-04-01 2019-04-01 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer
100 -0.0%
20.78
US$2,078 		100 -0.0% 20.78 US$2,078
2019-04-01 2019-04-01 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer
9,442 -2.6%
20.05
US$189,314 		9,442 -2.6% 20.05 US$189,314
2019-04-01 2019-04-01 PlS Planned sale
Kennedy Joseph T

General Counsel
53,060 -62.1%
20.03
US$1,062,993 		53,060 -62.1% 20.03 US$1,062,993
2019-03-06 2019-03-04 PlS Planned sale
Ekman Lars
36,700 -100.0%
21.71
US$796,830 		36,700 -100.0% 21.71 US$796,830
2019-03-06 2019-03-04 PlS Planned sale
Ekman Lars
98,677 -72.9%
21.16
US$2,088,074 		98,677 -72.9% 21.16 US$2,088,074
2019-03-06 2019-03-04 PlS Planned sale
1.3
THERO JOHN F

President and CEO

Executive Director
70,673 -3.3%
21.70
US$1,533,894 		70,673 -3.3% 21.70 US$1,533,894
2019-03-06 2019-03-04 PlS Planned sale
1.3
THERO JOHN F

President and CEO

Executive Director
179,327 -7.7%
21.15
US$3,793,340 		179,327 -7.7% 21.15 US$3,793,340
2019-03-01 2019-03-01 PlS Planned sale
Kalb Michael Wayne

SVP and CFO

Officer
22,075 -51.8%
22.59
US$498,582 		22,075 -51.8% 22.59 US$498,582
2019-03-01 2019-03-01 PlS Planned sale
Kalb Michael Wayne

SVP and CFO

Officer
70,801 -62.4%
22.06
US$1,561,721 		70,801 -62.4% 22.06 US$1,561,721
2019-03-01 2019-03-01 PlS Planned sale
Kalb Michael Wayne

SVP and CFO

Officer
7,124 -5.9%
20.89
US$148,795 		7,124 -5.9% 20.89 US$148,795
2019-03-01 2019-03-01 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
7,099 -2.0%
22.64
US$160,717 		7,099 -2.0% 22.64 US$160,717
2019-03-01 2019-03-01 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
35,398 -8.9%
22.10
US$782,197 		35,398 -8.9% 22.10 US$782,197
2019-03-01 2019-03-01 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
3,503 -0.9%
20.94
US$73,361 		3,503 -0.9% 20.94 US$73,361
2019-03-01 2019-02-28 PlS Planned sale
Kennedy Joseph T

General Counsel

Officer
27,231 -46.6%
20.72
US$564,172 		27,231 -46.6% 20.72 US$564,172
2019-03-01 2019-02-28 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
9,543 -2.6%
20.67
US$197,249 		9,543 -2.6% 20.67 US$197,249
2019-02-22 2019-02-22 PlS Planned sale
Peterson Kristine
Non-Executive Director
163,500 -100.0%
20.02
US$3,274,038 		163,500 -100.0% 20.02 US$3,274,038
2019-02-22 2019-02-22 PlS Planned sale
4.3
Zakrzewski Joseph S
Non-Executive Director
180,625 -68.1%
19.90
US$3,594,438 		180,625 -68.1% 19.90 US$3,594,438
2019-02-22 2019-02-22 PlS Planned sale
Kalb Michael Wayne

SVP and CFO

Officer
50,000 -70.9%
18.97
US$948,500 		50,000 -70.9% 18.97 US$948,500
2019-02-22 2019-02-22 PlS Planned sale
3.5
VAN HEEK G JAN
Non-Executive Director
203,382 -93.5%
20.02
US$4,071,423 		203,382 -93.5% 20.02 US$4,071,423
2019-02-15 2019-02-15 PlS Planned sale
Kalb Michael Wayne

SVP and CFO

Officer
25,000 -54.9%
17.58
US$439,525 		25,000 -54.9% 17.58 US$439,525
2019-02-01 2019-02-01 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
27,989 -7.3%
17.06
US$477,498 		27,989 -7.3% 17.06 US$477,498
2019-02-01 2019-01-31 PlS Planned sale
Kennedy Joseph T

General Counsel

Officer
42,624 -57.7%
17.49
US$745,468 		42,624 -57.7% 17.49 US$745,468
2019-02-01 2019-01-31 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
9,541 -2.7%
17.49
US$166,875 		9,541 -2.7% 17.49 US$166,875
2019-01-24 2019-01-24 PlS Planned sale
Kennedy Joseph T

General Counsel

Officer
609,115 -100.0%
17.66
US$10,754,717 		609,115 -100.0% 17.66 US$10,754,717
Explore more

More insider trading research around Amarin Corporation PLC

More insider trades in United Kingdom
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe